The pharmaceutical industry and ultrasound manufacturers are our main partners. We have been involved in epidemiological and prospective studies centered on the evolution of atherosceloris on superficial vessels. Through these studies the action of specific molecules on the arterial wall and plaques can be evaluated.
We help ultrasound manufacturers to improve their quantification tools by offering them to integrate dedicated functions adapted to their technical environment.

Moreover we maintain a technical awareness in order to improve the performance and precision of our quantification tools we develop.
To comply with regulatories we have obtained the iso9001 certification, the CE label and FDA approval, all essential to our activities.